Ligand Pharmaceuticals Incorporated
Methods and compositions for modulating hormone levels

Last updated:

Abstract:

Provided herein are compositions and methods for the treatment of androgen and estrogen receptors mediated conditions.

Status:
Grant
Type:

Utility

Filling date:

16 Sep 2019

Issue date:

29 Dec 2020